Related Experiment Video
Updated: Jul 23, 2025

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
CHARMM-GUI-Based Induced Fit Docking Workflow to Generate Reliable Protein-Ligand Binding Modes
1Departments of Biological Sciences, Chemistry, Bioengineering, and Computer Science and Engineering, Lehigh University, Bethlehem, Pennsylvania 18015, United States.
We developed a CHARMM-GUI induced fit docking (CGUI-IFD) workflow to accurately predict how drug molecules bind to protein targets, overcoming challenges in drug discovery.
Area of Science:
- Computational Chemistry
- Structural Biology
- Drug Discovery
Background:
- Molecular docking is crucial for structure-based drug discovery, predicting ligand-protein interactions.
- The induced fit effect, where protein binding sites change conformation, poses a challenge for traditional docking methods.
Purpose of the Study:
- To present a straightforward CHARMM-GUI induced fit docking (CGUI-IFD) workflow.
- To generate reliable protein-ligand binding modes by accounting for receptor flexibility.
Main Methods:
- The CGUI-IFD workflow refines ligand-binding site (LBS) conformations.
- It employs rigid receptor docking followed by high-throughput molecular dynamics (MD) simulations.
- Binding stability and energy are evaluated using RMSD and MM/GBSA.
Main Results:
- The CGUI-IFD workflow achieved an 80% success rate on a benchmark dataset of 258 cross-docking pairs.
- This success rate was defined as RMSD within 2.5 Å of experimental structures.
- The workflow demonstrated reliability in predicting binding modes for various protein targets.
Conclusions:
- The CGUI-IFD workflow provides a robust method for generating accurate ligand binding modes.
- It effectively addresses the induced fit challenge in molecular docking.
- This approach is expected to be valuable for cross-docking applications in drug discovery.
More Related Videos
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
The Equilibrium Binding Constant and Binding Strength
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Protein-protein Interfaces
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...